Last week, Linda Segal, principal and head of our life sciences practice, moderated a virtual roundtable panel on pandemic and risk mitigation hosted by the Maryland Tech Council. Panelists included Dr. William Hearl, CEO of Immunomic Therapeutics; Dr. Anne Lindblad, former CEO of Emmes; and John Trizzino, EVP of NOVAVAX.

If you would like to hear more about the panel or share your thoughts, please contact Linda Segal at 703.841.1700 x235 or lsegal@tmg-dc.com.